09 Oct 2024
Co-Founder & Chief Business Officer
Join us at BioTechX Europe - Basel, Switzerland.
On 9 October 2024 at 10:00 am CET, our Co-Founder and Chief Business Officer, Dr. Ivan Griffin, will chair 'The benefits of AI within drug discovery' panel discussion.
Throughout the event, you'll find our expert team at Booth 1116.
More info about BioTechX Europe
Ivan Griffin
Ivan has nearly 20 years of experience working with early-stage life science and technology companies. He was a Co-Founder of Benevolent having previously worked as a venture capitalist at IP Group Plc from 2005 to 2009 and at Nesta Investments from 2009 to 2014.
Back to events